Visit Us @
Synergy Centre TU Dublin, Tallaght, D24A386
Mail Us @
info@codlad.com
Call Us @
+353 851890752

Archive for March 25, 2021

FDA Approves New indication for Drug to Treat Neurogenic Detrusor Overactivity in Pediatric Patients

March 25, 2021

FDA Approves New indication for Drug to Treat Neurogenic Detrusor Overactivity in Pediatric Patients

Today, the U.S. Food and Drug Administration approved a new indication for Myrbetriq (mirabegron extended-release tablets) and Myrbetriq Granules (mirabegron for extended-release oral suspension) to…

FDA Approves New indication for Drug to Treat Neurogenic Detrusor Overactivity in Pediatric Patients FDA

Latest Posts

FDA Approves New Safety Warning and Revised Indication that Limits Use for Elevidys Following Reports of Fatal Liver Injury
FDA Approves New Safety Warning and Revised Indication that Limits Use for Elevidys Following Reports of Fatal Liver Injury
November 14, 2025
HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy
HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy
November 10, 2025
HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy
HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy
November 10, 2025